Recursion’s innovative drug discovery process integrates dry lab (experiments run in-silico), wet lab (traditional experiments), AI-powered data analysis, and LOWE (LLM-orchestrated Workflow ...

Recursion will have access to de-identified clinico-genomic data, collected from research participants who consent to participate in Helix’s extensive research network, which includes health ...